Wellgistics Secures Preferred EBV Pricing, Prepares PharmacyChain Integration
Wellgistics secured preferred pricing for eligibility and benefits verification services via EinsteinRx AI, enabling immediate provider access and preparing PharmacyChain integration. The EBV market is projected to expand from $2.39 billion in 2025 to $3 billion by 2030, underpinning new revenue and cost savings from Q2 2026.
1. Preferred Pricing Agreement
Wellgistics has secured contractual rights to preferred pricing for medical insurance eligibility and benefits verification (EBV) services, offering reduced per-transaction fees to its providers, partners and 6,500+ pharmacy network immediately through the EinsteinRx AI hub. The arrangement lays the groundwork for seamless EBV integration into PharmacyChain later this year.
2. EBV Market Growth
The EBV market is forecast to grow from $2.39 billion in 2025 to $3 billion by 2030, driven by rising billing complexity, increased claim denials and wider digital health record adoption. This expansion represents a substantial addressable market opportunity for Wellgistics’ AI-powered and blockchain-enabled platform services.
3. Strategic Revenue Impact
By leveraging preferred EBV pricing, Wellgistics plans to launch a new revenue stream in Q2 2026 and reduce operational costs for its pharmacy operations. This financial predictability supports the rollout of its GLP-1 and Forzet™ offerings and strengthens its end-to-end smart contracts solution for drug distribution.